| Product | 11.03M |
| Collaborative | 1.84M |
| Total revenue | 15.39M |
| Cost of product revenue | 8.67M |
| Research and development | 5.2M |
| Selling, general and administrative | 5.29M |
| Restructuring charges | |
| Total operating expenses | |
| Loss from operations | -3.77M |
| Interest and other income | |
| Interest expense | -1.41M |
| Gain on debt extinguishment upon conversion of convertible notes | |
| Gain on debt extinguishment upon repurchase of convertible notes | |
| Gain (loss) on net change in fair value of derivative assets and liabilities | 597K |
| Total other income (expenses), net | -813K |
| Net income (loss) from continuing operations | -4.58M |
| Net income (loss) from discontinued operations | 0 |
| Net income (loss) | |
| Less: Loss attributed to noncontrolling interests in consolidated entities - discontinued operations | |
| Net income (loss) attributed to Verenium Corporation | -4.58M |
| Continuing operations | |
| Discontinued operations | |
| Net income (loss) per share | |
| Shares used in calculating net income (loss) per share, basic and diluted | |